GlassScriptPhysician profile
Rubin Raju
NPI 1972868495
$4,427.95
in general payments reported to CMS, 2019-2025
17 companies · $1,757 in 2025
The $1,757 reported for 2025 was more than what 81% of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) providers received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $259 · 2022: $2,013 · 2023: $185 · 2024: $214 · 2025: $1,757.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,328 · Travel and Lodging: $443 · Consulting Fee: $300 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,327.66 |
| Travel and Lodging | $443.49 |
| Consulting Fee | $300.00 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $2,170.73 | 2021-2024 | Bulkamid, Axonics |
| Medtronic, INC. | $636.31 | 2025 | Altaviva |
| Escala Medical INC. | $311.00 | 2025 | |
| Bluewind Medical | $300.00 | 2025 | Revi |
| Femselect INC. | $251.38 | 2024-2025 | Enplace |
| Astellas Pharma US INC | $196.64 | 2023-2025 | Veozah |
| Baxter Healthcare | $146.34 | 2025 | Seprafilm, Adept, Floseal |
| Sumitomo Pharma America, INC. | $130.93 | 2023-2025 | Gemtesa, Myfembree |
| Intuitive Surgical, INC. | $51.79 | 2025 | |
| Mayne Pharma Commercial LLC | $50.91 | 2022-2025 | |
| Hologic Sales and Service, LLC | $44.84 | 2025 | Aptima, Thinprep 2000 Processor, Myosure Tissue Removal Device |
| Organon LLC | $34.20 | 2022-2023 | Nexplanon |
| Abbvie INC. | $22.42 | 2022 | |
| Urovant Sciences INC | $21.58 | 2022 | |
| Innovation Technologies INC | $21.53 | 2024 | Irrisept |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $21.16 | 2022 | |
| Dentsply Ih Ab | $16.19 | 2025 | Lofric |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rubin Raju listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.